SH006

· Nanjing Sanhome Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SH006, covering 2026-01-23 to 2026-01-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SH006 Injection Combination Therapy in Patients With Advanced Solid Tumors [Phase 1]